---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-032119"
form_type: "8-K"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2025-04-15T23:59:59+00:00"
generated_at: "2026-05-23T14:46:37.384950+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aditxt secures call option to purchase $25M Evofem convertible notes for $13M

## Summary
- Aditxt granted call option to acquire Evofem convertible notes (aggregate $25M principal) and purchase rights from Adjuvant funds for $13M.
- Option exercisable after Future Pak Note fully repaid, until June 30, 2025; exercise triggers $13M payment.
- If Aditxt does not provide $1.5M capital to Evofem by April 30, 2025, Adjuvant may transfer securities without consent.
- Evofem consents to assignment of notes and waives opinion of counsel requirements.

## SEC filing metadata
- accession: 0001213900-25-032119
- form_type: 8-K
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2025-04-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390025032119/0001213900-25-032119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390025032119/ea0238436-8k_aditxt.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-032119
- JSON: https://secwatch.observer/filing/0001213900-25-032119.json
- Plain text: https://secwatch.observer/filing/0001213900-25-032119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.